Navigation Links
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
Date:3/12/2010

CHADDS FORD, Pa., March 12 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today the appointment of Julie McHugh as the company's chief operating officer, effective March 15, 2010.

Most recently, Ms. McHugh was president and CEO for Nora Therapeutics, a venture capital backed biotech start-up developing novel therapies to prevent implantation failure in the setting of in-vitro fertilization and recurrent pregnancy loss.  Before joining Nora, she held senior positions at Johnson & Johnson during a twelve year period.  Her last role at J&J was Company Group Chairman for the Global Virology Business Unit. Before that she was President of Centocor, Inc., a J&J company. Previously, Ms. McHugh held marketing positions of increasing scope and accountability at Astra-Merck, Rhone-Poulenc Rorer (Sanofi Aventis) and SmithKline (GlaxoSmithKline).

Julie currently serves on the Board of Visitors for the Smeal College of Business of the Pennsylvania State University, the Board of Directors for the Nathaniel Adamczyk Foundation and was 2009 Chairman of the Board of Directors for the Pennsylvania Biotechnology Association. She received her Bachelor of Science degree from Pennsylvania State University and her Masters o
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015 BiondVax ... preliminary results from its BVX-006 Phase II clinical trial ... In this trial, M-001 was injected intramuscularly to volunteers ... an administration of the 2014/15 season trivalent influenza vaccine ... safe and well tolerated and induced humoral immune responses, ...
(Date:6/29/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Russell 1000 Index, effective June 26, 2015. The Russell ... of the U.S. equity universe. It is a subset ... of the largest securities based on a combination of ... "We are pleased to be added to this important ...
(Date:6/29/2015)... SAN JOSE, Calif. , June 29, 2015 ... its expert medical workstation lineup. The high-powered, multi-functional ... th generation Intel® Haswell Core ... processor. Both provide significant data processing and computing ... visual performance, making the unit well suited for ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
(Date:6/30/2015)... ... 2015 , ... This Fourth of July, Peacock Alley celebrates the ... work, tenacity, perseverance, commitment to quality, honesty and love of friends and family. These ... Gabler's simple love of quilts, Peacock Alley was fully realized and grown while raising ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Curly Hair ... 14, the largest beauty event in the US, featuring products from all over the ... Keeper™ Collection. The Collection is a line of hair styling products focused entirely on ...
(Date:6/29/2015)... City, NY (PRWEB) , ... June 30, 2015 ... ... honors Melanie Richards as a 2015-2016 inductee into its VIP ... leadership in business. NAPW is the nation’s leading networking organization exclusively for professional ...
(Date:6/29/2015)... ... June 30, 2015 , ... Leaders ... one of the industry’s premier thought leadership symposiums, “Harmony 2015” hosted by Massachusetts-based ... rehabilitation managers and other management and corporate personnel representing the skilled nursing and ...
(Date:6/29/2015)... ... ... The United States Equestrian Federation (USEF) is pleased to announce a ... Occupational Therapists of the U.S. Eventing Team. KORT also provided the official onsite ... , “The USEF is pleased to welcome the Kentucky Orthopedic Rehab Team as the ...
Breaking Medicine News(10 mins):Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:Curly Hair Solutions™ Showcases Entire Curl Keeper™ Collection at Cosmoprof Las Vegas July 12 - 14 2Health News:National Association of Professional Women Inducts Melanie Richards, DMD, of Powdersville Pediatric Dentistry, Into its VIP Woman of the Year Circle 2Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 2Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 3Health News:KORT Physical Therapy Announces Partnership with The United States Equestrian Federation 2
... 13 The American Association of Homes and ... than 60 aging and disability organizations to urge ... a part of health care reform legislation.The groups ... Call today and on a Congressional call-in ...
... CINCINNATI, May 13, 2009 Today, the United States ... favor of The Procter & Gamble Company (P&G) in ... Pharmaceuticals USA, Inc. The positive ruling protects P&G,s ... therapy Actonel(R) (risedronate sodium) tablets. Actonel is commercialized ...
... Irvine, Calif., May 13, 2009 A potential vaccine ... to slow the weakening of muscles associated with inclusion ... The finding brings new hope for IBM patients with ... wrists, forearms or quadriceps. There is no cure for ...
... 2009 Orange County Arthritis Walk(R)IRVINE, Calif., May 13 ... the Arthritis Foundation. The Orange County Great Park ... County Arthritis Walk(R) set to take place on Sunday, ... Foundation,s annual nationwide event to raise funds for arthritis ...
... The decision by the Centers for ... colonography, also known as "virtual" colonoscopy, a radiographic examination ... on the test,s potential as an appropriate option for ... of the primary issues identified by CMS is that ...
... 13 At a congressional hearing today in Washington, ... of Veterans Affairs to immediately expand use of ViziLite(R) ... oral abnormalities that could lead to cancer. David Bethune, ... ZILA ), developer and marketer of ViziLite Plus, addressed ...
Cached Medicine News:Health News:AAHSA Joins Sixty Aging and Disability Groups to Fight for Long-Term Services and Supports in Health Care Reform 2Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 2Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 3Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 4Health News:Vaccine slows progression of skeletal muscle disorder 2Health News:Take a Walk in the Great Park to Benefit the Arthritis Foundation 2Health News:Decision by Medicare's CMS to Deny Coverage for 'Virtual' Colon Cancer Tests Underscores Lack of Evidence on Cancer Prevention 2Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 2Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 3Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 4Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 5Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 6Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 7
... curtains or parting strip shields ... frame to form a free-standing, ... cleanliness to Class 10/ISO 3. ... lights, and ionizers are configured ...
Inquire...
Inquire...
Inquire...
Medicine Products: